期刊文献+

槲皮素诱导人肝癌HepG_2细胞凋亡的实验研究 被引量:13

Apoptosis of Human HepG_2 Cells Induced by Quercetin
暂未订购
导出
摘要 目的探讨槲皮素诱导HepG2细胞凋亡的作用机制。方法应用透射电镜观察药物作用组及对照组细胞形态学变化;AnnexinV荧光染色和流式细胞仪检测药物作用组及对照组HepG2细胞凋亡和死亡率,以及逆转录聚合酶链反应(RT-PCR)法检测药物作用组及对照组凋亡相关基因fas的变化。结果槲皮素对HepG2细胞的生长有明显的抑制作用,并诱导肿瘤细胞发生凋亡,凋亡细胞表现为细胞固缩、核染色质碎裂,流式细胞仪检测凋亡率为13.2%,细胞停在G1和G2期。AnnexinV标记的方法检测凋亡时发现,坏死与凋亡共存。在槲皮素诱导HepG2细胞凋亡过程中,凋亡相关基因fas转录水平比用药前增强。结论诱导凋亡为槲皮素抑癌的机制之一,槲皮素诱导HepG2细胞凋亡可能与fas基因表达有关。 Objective To study the mechanism of quercetin - induced apoptosis of human HepG2 cells. Methods The cellular morphology of each research group were observed by transmission electron microscope ; the cells were staining by Annexin V and the flow cytometry (FCM) were applied to detect apoptosis of the HepG2 cells ; and the reverse transcription polymerase chain reaction (RT- PCR) were applied to detect the genes related with apoptosis, such as fas. Results Quercetin had a evident effect on the growth of the human liver cancer HepG2 cells as well as apoptosis inducing. The morphous of HepG2 cells showed nuclear chromatine condensation and nuclear fragmentation. The apoptosis rate of HepG2 cell was 13.2% by FCM technolony and the cell cycle stopped at the G1 and G2 phase. The transcription level of the fas gene was enhanced. Conclusion Quercetin could induce apoptosis of the human HepG2 cells as a inhibitor of liver cancer. The mechanism of induction apoptosis may be related to the fas gene activation.
出处 《实用心脑肺血管病杂志》 2010年第3期310-311,共2页 Practical Journal of Cardiac Cerebral Pneumal and Vascular Disease
关键词 肿瘤细胞 培养 细胞凋亡/药物作用 槲皮素 Tumor cells Cultured Apoptosis/drug effects Quercetin
  • 相关文献

参考文献3

二级参考文献33

  • 1蔡讯,陈芳源,韩洁英,顾春红,钟华,欧阳仁荣.槲皮素恢复柔红霉素在白血病耐药细胞K562/ADM和HL-60/ADM中的分布[J].癌症,2004,23(12):1611-1615. 被引量:8
  • 2Hertog M G, Hollman P C, Katan M B, et al. Intake of potentially anticarcinogenic flavonoids and their determinants in adults in the netherlands [J]. Nutr Cancer, 1993,20(1) :21-29.
  • 3Hertog M G, Feskens E J, Hollman P C, et al. Dietary antioxidant flavonoids and risk of coronary heart disease: the Zutphen elderly study [J]. Lancet, 1993,342 (8878) : 1007-1011.
  • 4Swain T. The flavonoids[M]. London: Chapman & Hall 1975:1096-1129.
  • 5Torchilin V P. Recent advances with liposomes as pharmaceutical carriers [J]. Nat Rev Drug Discov, 2005,4(2) : 145-160.
  • 6Tardi P, Choice E, Masin D, et al. Liposomal encapsulation of topotecan enhances anticancer efficacy in murine and human xenograft models [J]. Cancer Res, 2000,60(13) :3389-3393.
  • 7Peer D, Margalit R. Loading mitomycin C inside long circulating hyaluronan targeted nano-liposomes increases its antitumor activity in three mice tumor models [J]. Int J Cancer, 2004,108 (5) : 780-789.
  • 8Yoshiji H, Kuriyama S, Hickin D J, et al. The vascular endothelial growth factor receptor KDR/FIk-1 is a major regulator of malignant ascites formation in the mouse hepatocellular carcinoma model [J]. Hepatology, 2001,33(4) :841-847.
  • 9Muther R S, Bennett W M. Effects of dimethyl sulfoxide on renal function in man [J]. JAMA, 1980,244(18):2081-2083.
  • 10Marshall L F, Camp P E, Bowers S A. Dimethyl sulfoxide for the treatment of intracranial hypertension: A preliminary trial[J]. Neurosurgery, 1984, 14(6) :659-663.

共引文献35

同被引文献167

引证文献13

二级引证文献110

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部